Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07254624

Pilot Assessment of Continuous Glucose Monitor for Post-meal Glucose Responses to Herbs and Spices.

Glucosidase Inhibitors and Glucose Metabolism

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether continuous glucose monitoring is sensitive to quantifying the glucose response related to consumption of a starchy vegetable (potato) in combination with or separate from consumption of herbs and spices at the same meal.

Detailed description

This is a pilot study which will enroll a maximum of 10 participants. There will be 3 different food entree preparations that participants will consume (1 entree per day within the 10 day period). The order in which participants eat the different entrees will be randomized. The 3 different food entree preparations are as follows: 1) prepared potato entree with no herbs and spices, 2) prepared potato entree paired with herbs and spices, 3) prepared potato entree with herbs and spices consumed at a subsequent meal. Following enrollment, participants will be randomized to the order of entree preparation types and provided all of the entrees with the instructions for food preparation and order of consumption noted when they arrive at the scheduled study visit. The entrees will be standardized for caloric content, composition, and preparation method. Post-consumption glucose responses will be recorded by continuous glucose monitors, which will be provided to participants at the first study visit.

Conditions

Interventions

TypeNameDescription
OTHERMix of five herbs and spicesHerb and spice blend of dried oregano, basil, rosemary, garlic powder and onion powder
OTHERPotato entreeA potato entree with a fixed macronutrient and calorie content, and standardized preparation method to evoke a post-prandial glucose response

Timeline

Start date
2026-03-16
Primary completion
2026-11-01
Completion
2027-11-01
First posted
2025-11-28
Last updated
2026-03-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07254624. Inclusion in this directory is not an endorsement.